ChloraSolv is awarded on wound care tender in Region Kalmar Country Council and its municipalities

During the fall of 2019, RLS Global has worked intensively on the Swedish market with the aim to establish ChloraSolv as a product in the Swedish regions. In parallel, RLS has worked in close collaboration with OneMed to penetrate the market (municipalities and regions) where OneMed has agreements. As RLS has communicated in the past, the work carried out during the autumn of 2019 will generate positive results during Q1 and Q2 2020.

RLS can now inform that ChloraSolv has been awarded on the wound care tender agreement in the Kalmar County Council and its municipalities. The contract is valid as of 20th of March 2020. The outcome of the clinical evaluation has been very positive and ChloraSolv can now be offered to healthcare providers in the region.

“The law on public procurement requires that the regions clinically evaluate new technologies. It is a positive recognition that we now are now approved in our first country council. RLS has now full access to establish ChloraSolv in this region, says Karin Fischer, CEO of RLS Global. We are convinced that we will achieve more agreements of this nature in the near future, continues Karin.”

 

Trading place and certified advisor

RLS Global’s shares has been listed on the Nasdaq First North since 17th May, 2017 and trading takes place under the short name RLS. Certified Adviser is Erik Penser Bank, telephone +46 8 463 83 00, Email: certifiedadviser@penser.se.
During the period 2012 - 2017, the company was listed on Aktietorget.

 

Contact information

 

Karin Fischer, CEO
E-mail: karin.fischer@rlsglobal.se
Telephone: +46 702-48 46 51

 

Anders Husmark, CBDO RLS Global AB
E-mail: anders.husmark@rlsglobal.se
Telefon: +46 724 50 94 03

 

RLS Global AB is a medical technology company within Life Science. Based on the company's unique hypochlorite platform, RLS  Global develop products for some of our most common illnesses in wound and oral care. RLS Global has a portfolio of strong brands, including ChloraSolv® and Carisolv®. The company is listed on Nasdaq First North with Erik Penser Bank as Certified Adviser, telephone +46 (0) 8 463 83 00, email: certified adviser@penser.se. Read more at www.rls.global

About Us

For many years, RLS Global has worked with Oral Care specialists, pioneering new therapies for Oral Care and their patients. We are now taking another major step toward easier and more effective care within Wound Care. We will continue to work with Healthcare Professionals to ensure to develop a treatment that further helps deliver the best care for each patient. The method is clinically proven and saves the patient a lot of suffering. Our focus is on caring for patients, developing efficient and safe products that offer gentle treatment methods.

Subscribe

Documents & Links